EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Immunology, endocrine & metabolic agents in medicinal chemistry

Description
(Formerly 'Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents')

 

Status
active
Indexing
BIOSIS, Chemical Abstracts, EMBASE, BIOSIS Previews, BIOSIS Reviews Report and Meetings, Google, Google Scholar, Genamics JournalSeek
Predecessor
Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents
Subject

Source type
Journal
Publisher
ISBN ISSN
1871-5222
First volume
1
Last volume
8+
Homepage

Source type
Journal
Publisher
ISBN ISSN
1871-5222
First volume
6
Last volume
8+
Homepage
Description
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in the medicinal chemistry and rational drug design for the discovery of new Immunology, Endocrine & Metabolic Agents. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in Immunology, Endocrine & Metabolic medicinal chemistry.

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in Immunology, Endocrine & Metabolic drug discovery.











Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )